1887

Abstract

We have previously shown that the antiviral state of explanted mouse peritoneal macrophages (PM) decays during culture and that this decay is much more rapid in PM than it is in PM. Moreover, PM can transfer the antiviral state to other cells, whereas PM cannot. treatment of PM with different agents [i.e., bacterial lipopolysaccharide (LPS), interferon (IFN)-, tumour necrosis factor (TNF)-, macrophage colony-stimulating factor (M-CSF) and antibody to Mac-1 antigen] induced an antiviral state to vesicular stomatitis virus (VSV) which was inhibited by antibodies to IFN-. Treatment of PM with LPS or IFN- resulted in greater accumulation of IFN- mRNA, whereas no change in the barely detectable levels of IFN- mRNA was observed. Marked accumulation of IFN- mRNA was also observed in PM after TNF- treatment. M-CSF and IFN- (but not LPS) also induced an IFN-mediated antiviral state in PM. Low levels of spontaneous transcription of IFN- mRNA were detected in nuclei from PM. Treatment of PM with IFN- for 3 h resulted in the accumulation of IFN- mRNA without any concomitant increase in the transcription of the IFN- gene, as determined by run-on transcription assays with isolated nuclei. The addition of as little as 1 international unit/ml of IFN- to PM resulted in a 100-fold inhibition of VSV yield. As antibodies to IFN-/ inhibited only a portion of the IFN--induced antiviral state, such an antiviral state might reflect the synergism between IFN- and endogenous IFN-. In fact, the addition of low doses of both IFN- and IFN- to either or PM resulted in synergistic antiviral effects. treatment of mice with granulocyte-macrophage (GM)-CSF, M-CSF, IFN- or Newcastle disease virus rendered peritoneal cells capable of transferring an antiviral state. These results indicate that (i) various stimuli can induce IFN- production by PM, (ii) PM spontaneously transcribe low levels of IFN- mRNA, even though they cannot transfer an antiviral state, (iii) different stimuli, but not LPS, induce a normal IFN response in PM, (iv) IFN- increases the accumulation of IFN- mRNA in PM by post-transcriptional mechanisms and (v) IFN- may act synergistically with endogenous IFN- in inducing a potent antiviral state to VSV in PM.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-11-2585
1990-11-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/11/JV0710112585.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-11-2585&mimeType=html&fmt=ahah

References

  1. Belardelli F., Vignaux F., Proietti E., Gresser I. 1984; Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus. Proceedings of the National Academy of Sciences, U.S.A 81:602–606
    [Google Scholar]
  2. Belardelli F., Gessani S., Proietti E., Locardi C., Borghi P., Watanabe Y., Kawade Y., Gresser I. 1987; Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons. Journal of General Virology 68:2203–2212
    [Google Scholar]
  3. Bocci V. 1981; Production and role of interferon in physiological condition. Biological Reviews 56:59–85
    [Google Scholar]
  4. Chirgwin J. M., Przybyla A. E., Macdonald R. J., Rutter W. J. 1979; Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
    [Google Scholar]
  5. Czarniecki C. W., Fennie C. W., Powers D. B., Estell D. A. 1984; Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta and gamma interferons. Journal of Virology 49:490–496
    [Google Scholar]
  6. Ding A., Wright S. D., Nathan C. 1987; Activation of mouse peritoneal macrophages by monoclonal antibodies to Mac-1 (complement receptor type 3). Journal of Experimental Medicine 165:733–749
    [Google Scholar]
  7. Duc Dodon M., Vogel S. N. 1985; Analysis of effect of lipopolysaccharide and interferon on murine macrophages: modulation of elastase secretion in vitro. Infection and Immunity 49:709–714
    [Google Scholar]
  8. Enoch T., Zinn K., Maniatis T. 1986; Activation of the human beta-interferon gene requires an interferon-inducible factor. Molecular and Cellular Biology 6:801–810
    [Google Scholar]
  9. Fleischmann W. R.Jr 1982; Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence. Cancer Research 42:869–875
    [Google Scholar]
  10. Friedman R. L., Manly S. P., Mcmanon M., Kerr I. M., Stark G. R. 1984; Transcriptional and post-transcriptional regulation of interferon-induced gene expression in human cells. Cell 38:745–755
    [Google Scholar]
  11. Fujita T., Sakakibara J., Sudo Y., Miyamoto M., Kimura Y., Taniguchi T. 1988; Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO Journal 7:3397–3405
    [Google Scholar]
  12. Fujita T., Kimura Y., Miyamoto M., Barsoumian E. L., Taniguchi T. 1989; Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature; London: 337270–272
    [Google Scholar]
  13. Gessani S., Belardelli F., Borghi P., Boraschi D., Gresser I. 1987; Correlation between the lipopolysaccharide response of mice and the capacity of mouse peritoneal cells to transfer an antiviral state. Role of endogenous interferon. Journal of Immunology 139:1991–1998
    [Google Scholar]
  14. Gessani S., Mccandless S., Baglioni C. 1988; The glucocorticoid dexamethasone inhibits synthesis of interferon by decreasing the level of its mRNA. Journal of Biological Chemistry 283:7454–7458
    [Google Scholar]
  15. Gessani S., Belardelli F., Pecorelli A., Puddu P., Baglioni C. 1989; Bacterial lipopolysaccharide and gamma interferon induce transcription of beta interferon mRNA and interferon secretion in murine macrophages. Journal of Virology 63:2785–2789
    [Google Scholar]
  16. Greenberg M. E., Ziff E. B. 1984; Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature; London: 311433–438
    [Google Scholar]
  17. Gresser I., Vignaux F., Belardelli F., Tovey M. G., Maunoury M. T. 1985; Injection of mice with antibody to mouse interferon alpha/beta decreases the level of 2′-5′ oligo-adenylatesynthetase in peritoneal macrophages. Journal of Virology 53:221–227
    [Google Scholar]
  18. Higashi Y., Sokawa Y., Watanabe Y., Kawade Y., Ohno S., Takaoka C., Taniguchi T. 1983; Structure and expression of a cloned cDNA for mouse IFN-beta. Journal of Biological Chemistry 258:9522–9529
    [Google Scholar]
  19. Jacobsen H., Mestan J., Mittnacht S., Dieffenbach C. W. 1989; Beta interferon subtype 1 induction by tumor necrosis factor. Molecular and Cellular Biology 9:3037–3042
    [Google Scholar]
  20. Kohase M., Henriksen-Destefano May K. T., Vilček J., Sehgal P. B. 1986; Induction of beta-interferon by TNF: a homeostatic mechanism in the control of cell proliferation. Cell 45:659–666
    [Google Scholar]
  21. Lee M. T., Warren M. K. 1987; CSF-1-induced resistance to viral infection in murine macrophages. Journal of Immunology 138:3019–3022
    [Google Scholar]
  22. Lewis J. A., Huq A., Shan B. 1989; Interferons beta and gamma act synergistically to produce an antiviral state in cells resistant to both interferons individually. Journal of Virology 63:4569–4578
    [Google Scholar]
  23. Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata T., Taniguchi T. 1988; Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta regulatory elements. Cell 54:903–913
    [Google Scholar]
  24. Proietti E., Gessani S., Belardelli F., Gresser I. 1986a; Mouse peritoneal cells confer an antiviral state on mouse cell monolayers: role of interferon. Journal of Virology 57:456–463
    [Google Scholar]
  25. Proietti E., Carpinelli G., Di Vito M., Belardelli F., Gresser I., Podo F. 1986b; 31P nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice. Cancer Research 46:2849–2857
    [Google Scholar]
  26. Raj N. B. K., Pitha P. M. 1983; Two levels of regulation of beta-interferon gene expression in human cells. Proceedings of the National Academy of Sciences, U.S.A 80:3923–3927
    [Google Scholar]
  27. Springer T., Galfré G., Secher D. S., Milstein C. 1979; Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. European Journal of Immunology 9:301–306
    [Google Scholar]
  28. Tovey M. 1989; The expression of cytokines in the organs of normal individuals: role in homeostasis. A review. Journal of Biological Regulators and Homeostatic Agents 2:87–92
    [Google Scholar]
  29. Vogel S. N., Fertsch D. 1984; Endogenous interferon production by endotoxin-responsive macrophages provides an autostimulatory differentiation signal. Infection and Immunity 45:417–423
    [Google Scholar]
  30. Vogel S. N., Fertsch D. 1987; Macrophages from endotoxin-hyporesponsive (Lpsd) C3H/HeJ mice are permissive for vesicular stomatitis virus because of reduced levels of endogenous interferon: possible mechanism for natural resistance to virus infection. Journal of Virology 61:812–818
    [Google Scholar]
  31. Vogel S. N., Rosenstreich D. L. 1979; Defective Fc receptor-1 mediated phagocytosis in C3H/HeJ macrophages. I. Correction by lymphokine-induced stimulation. Journal of Immunology 123:2842–2850
    [Google Scholar]
  32. Vogel S. N., Weedon L. L., Moore R. N., Rosenstreich D. L. 1982; Correction of defective macrophage differentiation in C3H/HeJ mice by interferon-like molecule. Journal of Immunology 128:380–387
    [Google Scholar]
  33. Watson J., Largen M., Mcadam K. P. W. J. 1978; Genetic control of endotoxic responses in mice. Journal of Experimental Medicine 47:39–49
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-11-2585
Loading
/content/journal/jgv/10.1099/0022-1317-71-11-2585
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error